As an adipokine that facilitates lipid and glucose metabolism, adiponectin levels were reported to be lower in the blood concentrations of persons with schizophrenia treated with antipsychotics [80], particularly those suffering from metabolic syndrome [81], compared with their healthy controls. This evidence concerns the gene ADIPOQ and schizophrenia.